loxoprofen Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Loxoprofen is a nonsteroidal anti-inflammatory drug (NSAID) in the propionic acid derivatives group, which also includes ibuprofen and naproxen among others. It is available in some countries for oral administration. A transdermal preparation was approved for sale in Japan in January 2006; medicated tape and gel formulations followed in 2008 and 2010.   Wikipedia

Chemistry

  • SMILES: CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1
  • InChIKey: YMBXTVYHTMGZDW-UHFFFAOYSA-N
  • Mol. Mass: 246.31
  • ALogP: 2.79
  • ChEMBL Molecules:
    loxoprofen  
    loxoprofen sodium  
More Chemistry

Pharmacology

Alternative names

156-s | 2-(4-((2-oxocyclopentyl)methyl)phenyl)propionic acid | 2-ocppp | cs 600 | cs-600 | loxonin | loxoprofen | loxoprofen alcohol | loxoprofen sodium | loxoprofen sodium dihydrate | loxoprofen sodium hydrate | loxoprofen sodium, (r*,s*)-isomer | sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate dihydrate | sodium loxoprofen

Organizations (21)

Research & Development (21)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (13)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Arthritis, Rheumatoid (Phase 2)

Back Pain (Phase 2)

Chronic Pain (Phase 2)

Fever (Phase 3)

Healthy Volunteers (Phase 4)

Low Back Pain (Phase 3)

Lumbar Vertebrae (Phase 3)

Pain (Phase 3)

Respiratory Tract Infections (Phase 3)

Spondylitis, Ankylosing (Phase 4)

Sprains and Strains (Phase 2)

Therapeutic Equivalency (Phase 1)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial Organizations: 21

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue